Workflow
Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update
AADIAerpio Pharmaceuticals(AADI) Prnewswire·2024-10-30 20:05

Group 1 - Aadi Bioscience, Inc. will report its third quarter 2024 financial results on November 6, 2024 [1] - The company focuses on the commercialization of FYARRO® for treating adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumor (PEComa) [2]